Log In
BCIQ
Print this Print this
 

Zanipress (Zanitek)

  Manage Alerts
Collapse Summary General Information
Company Recordati S.p.A.
DescriptionFixed combination of lercanidipine and enalapril
Molecular Target Not available
Mechanism of Action 
Therapeutic ModalitySmall molecule: Combination
Latest Stage of DevelopmentMarketed
Standard IndicationHypertension
Indication DetailsTreat hypertension
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today